Cite
HARVARD Citation
Tanaka, Y. et al. (2019). Efficacy and safety of intravenous belimumab in Japanese patients with systemic lupus erythematosus: A subgroup analysis of a phase 3 randomized placebo-controlled trial. Modern rheumatology. 29 (3), pp. 452-460. [Online].